lonza group ag-reg (LONN) Details

Lonza Group AG supplies products and services to the pharmaceutical and biotechnology, healthcare, and life-science industries worldwide. Its Custom Manufacturing segment manufactures active ingredients that are used in critical drugs for treating patients with cardiovascular diseases, cancer, neurological, and infectious diseases. The company’s Life Science Ingredients segment offers products used in nutrition, microbial control, and selected industrial markets. This segment’s ingredients range from nutritional ingredients that support improved health to complex chemical intermediates for the agricultural industry. It serves manufacturers of consumer and health products, distributors, formulators, and service companies. The company’s Microbial Control segment provides chemistry-based and related solutions to destroy or selectively inhibit the growth of harmful microorganisms in the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. Its product range includes swimming pool and spa treatment chemicals, active biocides for hospital disinfectants, and metalfree wood preservatives, as well as sanitizers and household cleaning products. The company’s Bioscience segment develops tools that help life science customers to discover, develop, and test therapeutics. Its products range from cell culture and molecular biology tools for life-science research to media used in the production of therapeutics and tests for microbial detection. This segment also offers custom manufacturing services to cell therapy companies. It serves pharmaceutical and biotechnology companies, and academic and government research organizations. The company was founded in 1897 and is headquartered in Basel, Switzerland.

lonza group ag-reg (LONN) Top Compensated Officers